Health Care & Life Sciences » Pharmaceuticals | Amarillo Biosciences Inc.

Amarillo Biosciences Inc.

Amarillo Biosciences Inc.
Stock Exchange Other OTC
EPS
$0.04
Market Cap
$12.98 M
Shares Outstanding
39.66 M
Public Float
24.17 M

Profile

Address
4134 Business Park Drive
Amarillo Texas 79110
United States
Employees -
Website http://www.amarbio.com
Updated 07/08/2019
Amarillo Biosciences, Inc. engages in developing biologics for the treatment of human and animal diseases. It focuses on research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha that is administered in a proprietary low dose oral form. The company was founded by Joseph M.

Financials

View All

Stephen T. Chen
Chairman, President, Chief Executive Officer & COO
Yasushi Chikagami
Director